Skip to content

Effect of Remote Ischemic Conditioning on Vascular Health in Stroke Patients

Effect of Remote Ischemic Conditioning on Vascular Health in Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03635177
Acronym
VISP
Enrollment
30
Registered
2018-08-17
Start date
2019-03-10
Completion date
2022-10-20
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Lacunar

Brief summary

The main aim of the current study is to assess cardiovascular effects of remote ischemic conditioning in patients who have suffered from stroke. A group of stroke patients will be subjected to four weeks of daily remote ischemic conditioning and four weeks of placebo and vascular function is assessed as a primary outcome.

Detailed description

Remote ischemic preconditioning (RIC) has been shown to reduce myocardial damage in association with a myocardial infarct but less is known about the potential effects on vascular function in patients who have suffered a stroke. RIC is a procedure by which blood flow to a limb is repeatedly occluded during a short period by an inflatable cuff. This project evaluates the effect of a two week period with RIC on vascular function and cerebral blood flow velocity as well as on factors associated with blood clot formation in patients who have suffered a stroke. The study also aims to provide mechanistic insight into the beneficial effects of the RIC procedure. Subjects are patients who within the past five years have suffered from lacunar infarct. The study is of a cross-over design with two weeks of homebased RIC treatment and two weeks of control period in a randomized order. Before and after the experimental periods the subjects undergo a number of tests assessing general health status, vascular function and cerebral blood flow velocity. Skeletal muscle samples are obtained for the determination of selected proteins related to vascular function and angiogenesis and blood samples are obtained for the determination of platelet function. .

Interventions

PROCEDURERemote ischemic conditioning

Four weeks of daily ischemic conditioning and four weeks of sham ischemic conditioning in a cross over design

Sponsors

Herlev Hospital
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The patients will undergo two weeks of the intervention and two weeks of controlperiod, separated by three weeks. The intervention consists of inflating a cuff on the upperarm to 200 mmHg for 4 x 5 minutes, performed every day. The control period includes no specific intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical symptoms and corresponding computer tomographytomography/magnetic resonance (CT/MR)-scanning results for lacunar infarct within past five years. * Small vessel disease stroke (lacunar infarct) is defined by the TOAST criteria

Exclusion criteria

Clinical significant carotid stenosis. Cardioembolic stroke * Clinically significant chronic diseases other than lacunar infarct and associated factors * Current or past smoker within the past ten years * Current treatment with beta-blockers, peroral steroids or NSAIDS * Alcohol- or drug-addiction. * Pregnant or lactating. * Inability to understand the content of the study information provided.

Design outcomes

Primary

MeasureTime frameDescription
Flow mediated dilationChange from baseline to 4 weeksAssessment of brachial artery dilation after 5 min occlusion of upper arm by cuff

Secondary

MeasureTime frameDescription
Cerebral vascular function- motorparadigm taskChange from baseline to 4 weeksAssessment of change in cerebral blood flow velocity with motorparadigm task
Skeletal muscle blood flowChange from baseline to 4 weeksFemoral arterial blood flow measured at rest and during one leg knee extensor exercise
Platelet reactivityChange from baseline to 4 weeksPlatelet reactivity is assessed in platelets isolated from blood samples
Blood clot structure-gel pointChange from baseline to 4 weeksBlood clot structure is assessed by gel point
Blood clot structure-fractal analysisChange from baseline to 4 weeksBlood clot structure is assessed by fractal analysis
Cerebral vascular function-visual taskChange from baseline to 4 weeksAssessment of change in cerebral blood flow velocity with visual task
Plasma proteinsChange from baseline to 4 weeksProtein amount is determined in plasma
Plasma lipidsChange from baseline to 4 weeksLipid concentration is determined in plasma
Oral glucose tolerance test (OGTT)Change from baseline to 4 weeksAn oral glucose tolerance test is conducted by assesment of blood glucose and insulin before and after ingestion of glucose
Body compositionChange from baseline to 4 weeksBody composition is assessed by dual energy x-ray absorptiometry
Skeletal muscle proteinsChange from baseline to 4 weeksProteins associated with angiogenesis and vascular function are assessed in skeletal muscle samples obtained from the thigh muscle

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026